timothy grass pollen allergen: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
timothy grass pollen allergen: clinical details
Prescribing considerations
- Initiation requires an allergy-experienced physician and access to treatment for allergic reactions.
- Confirm clinically relevant grass pollen allergy by skin-prick testing and/or specific IgE.
- Assess asthma control, oral health, previous systemic reactions to grass immunotherapy, cardiac disease and whether adrenaline could be used safely.
- Clinical experience is lacking below age 5 and in adults aged 65 years or older.
- Vaccination may proceed after assessment of the patient's general condition.
Contraindications and cautions
- Hypersensitivity to an excipient
- Malignancy or systemic immune disease, including autoimmune, immune-complex or immunodeficiency disorders
- Severe inflammatory oral disease
- Uncontrolled or severe asthma
Monitoring
- Observe the first administration under medical supervision and discuss management of reactions.
- Review asthma deterioration and systemic or troublesome local allergic symptoms promptly.
- Assess persistent dysphagia, dyspepsia or heartburn for possible eosinophilic oesophagitis.
- Assess oral healing following surgery, extraction or loss of a deciduous tooth.
Clinical pharmacology
A standardised Timothy grass pollen extract administered sublingually to modify allergen-specific immunity. Significant systemic absorption is not expected; allergenic proteins are thought to be broken down into amino acids and small peptides.
Formulation and product differences
- The selected product is a white to off-white sublingual lyophilisate that disperses beneath the tongue.
- Excipients are fish-derived gelatine, mannitol and sodium hydroxide.
- Severe fish allergy is not a listed contraindication, but additional awareness is advised when initiating treatment.
- It is essentially sodium-free.
timothy grass pollen allergen interactions
Formal human interaction studies have not been conducted. Important considerations include:
Antihistamines, corticosteroids and mast-cell stabilisers
These may increase tolerance of local reactions; their use should be reviewed rather than stopped without advice.
Beta-blockers, tricyclic antidepressants, monoamine oxidase inhibitors and COMT inhibitors
These may complicate the use or tolerability of adrenaline if anaphylaxis occurs, so treatment should be reviewed before initiation.
Other allergen immunotherapy
Evidence about simultaneous treatment with other allergens is limited and specialist assessment is required.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.